858
J. Naga Siva Rao, R. Raghunathan / Tetrahedron Letters 53 (2012) 854–858
(g) Enderlin, G.; Taillefumier, C.; Didierjean, C.; Chapleur, Y. Tetrahedron:
Asymmetry 2005, 16, 2459–2474; (h) Marca, E.; Delso, I.; Tejero, T.; Vázquez, J.
T.; Dorta, R. L.; Merino, P. Tetrahedron Lett. 2009, 50, 7152–7155.
(c) ((3S,30R,40S,4a0R,4b0S,10a0S)-40-Acetoxy-10,2-dioxo-10,30,40,4a0,4b0,50,60,70,
80,10a0-decahydrospiro[indoline-3,100-pyrano[4,3-a]indolizine]-30-yl)methyl
acetate (11): Isolated yield: 80% (0.31 g) Synthesized from
a,b-unsaturated
11. (a) Smellie, I. A. S.; Fromm, A.; Paton, R. M. Tetrahedron Lett. 2009, 50, 4104–
4106; (b) Nath, M.; Mukhopadhyay, R.; Bhattacharjya, A. Org. Lett. 2006, 8,
317–320; (c) Gallos, J. K.; Koftis, T. V.; Koumbis, A. E.; Moutsos, V. I. Synlett
1999, 1289–1291; (d) Gallos, J. K.; Koumbis, A. E. Curr. Org. Chem. 2003, 7, 397–
426.
12. (a) Neto, V.; Granet, R.; Krausz, P. Tetrahedron 2010, 66, 4633–4646; (b)
Kuijpers, B. H. M.; Groothuys, S.; Keereweer, A.; Bram, R.; Quaedflieg, P. J. L. M.;
Blaauw, R. H.; van Delft, F. L.; Rutjes, F. P. J. T. Org. Lett. 2004, 6, 3123–3126; (c)
Hotha, S.; Anegundi, R. I.; Natu, A. Tetrahedron Lett. 2005, 46, 4585–4588; (d)
Koumbis, A. E.; Gallos, J. K. Curr. Org. Chem. 2003, 7, 771–797; (e) Dedola, S.;
Hughes, D. L.; Nepogodiev, S. A.; Rejzek, M.; Field, R. A. Carbohydr. Res. 2010,
345, 1123–1134.
13. (a) Karthikeyan, K.; Kumar, R. S.; Muralidharan, D.; Perumal, P. T. Tetrahedron
Lett. 2009, 50, 7175–7179; (b) Sirisha, N.; Raghunathan, R. Tetrahedron Lett.
2010, 51, 2515–2518; (c) Prasanna, R.; Purushothaman, S.; Raghunathan, R.
Tetrahedron Lett. 2010, 51, 4538–4542; (d) Deb Barman, P.; Sanyal, I.; Mandal,
S. B.; Banerjee, A. K. Synthesis 2011, 21, 3563–3568.
14. (a) Rajesh, R.; Raghunathan, R. Tetrahedron Lett. 2010, 51, 5845–5848; (b)
Purushothaman, S.; Raghunathan, R. Tetrahedron Lett. 2009, 50, 6848–6850; (c)
Arumugam, N.; Raghunathan, R. Tetrahedron 2010, 66, 969–975.
15. Ramu Sridhar, P.; Ramaiah Prabhu, K.; Chandrasekaran, S. Eur. J. Org. Chem.
2004, 4809–4815.
sugar lactone 1a (0.2 g, 0.087 mmol), isatin (0.129 g, 0.087 mmol), and
piperidine-2-carboxylic acid (0.169, 0.132 mmol),white solid. Mp = 150–
151 °C.1H NMR (CDCl3, 300 MHz): d 1.18–1.23 (m, 3H), 1.29 (s, 3H), 1.35–1.42
(m, 1H), 1.97 (s, 3H), 2.0–2.07 (m, 2H), 2.20–2.23 (m, 2H), 2.99–3.06 (m, 1H),
3.41–3.61 (m, 2H), 4.11–4.20 (m, 2H), 5.15–5.21 (m, 1H), 5.27–5.31 (m, 1H), 6.75
13
(d, J = 7.5 Hz, 1H), 7.03 (t, J = 7.5 Hz, 1H), 7.09–7.20 (m, 2H), 7.90 (s, 1H).
C
NMR (CDCl3, 75 MHz): d 19.2, 20.6, 23.7, 25.0, 32.3, 44.4, 44.6, 46.1, 61.7, 62.9,
64.5, 72.7, 73.7, 109.3, 123.5, 124.7, 128.8, 129.4, 140.9, 169.1, 169.7, 170.6,
178.3. IR (KBr)
C
+3.39 (c 0.4, CH2Cl2).
v
max: 1712, 1744, 3296 cmꢀ1. m/z 442.17. Anal. Calcd for
23H26N2O7: C, 62.43; H, 5.92; N, 6.33. Found: C, 62.53; H, 5.98; N, 6.40. ½a D27:1
ꢁ
(d) ((3S,3a0S,60R,70R,7a0R)-70-Acetoxy-20-methyl-2,40-dioxo-20,3a0,40,60,70,
7a0-hexahydro-10H-spiro[indoline-3,30-pyrano[4,3-c]pyrrole]-60-yl)methyl
acetate (12): Isolated yield: 86% (0.3 g) Synthesized from a,b-unsaturated sugar
lactone 1b (0.2 g, 0.087 mmol), isatin (0.129 g, 0.087 mmol), and sarcosine
(0.117 g, 0.132 mmol), white solid. m.p =110–111 °C.1H NMR (CDCl3, 300 MHz):
d 2.08 (s, 3H), 2.12 (s, 3H), 2.14 (s, 3H), 3.02–3.11 (m, 1H), 3.34–3.39 (m, 2H),
3.64 (d, J = 11.1 Hz, 1H), 4.26–4.30 (m, 2H), 5.19–5.20 (m, 1H), 5.25–5.29 (m,
1H), 6.84 (d, J = 7.5 Hz, 1H), 7.1 (t, J = 7.5 Hz, 1H), 7.23–7.28 (m, 2H), 8.01 (s, 1H).
13
C NMR (CDCl3, 75 MHz): d 20.7, 20.8, 34.3, 38.5, 49.9, 55.9, 62.2, 66.6, 74.0,
74.8, 110.3, 123.4, 123.9, 128.7, 129.9, 141.5, 169.1, 169.9, 170.5, 177.7. IR (KBr)
v
max: 1708, 1743, 3296 cmꢀ1. m/z 402.14; Anal. Calcd for C20H22N2O7: C, 59.70;
16. General procedure for the synthesis of pyrrolidinyl-spirooxindole
derivatives: To a solution of isatin/N-substituted isatin (1 equiv) and cyclic
H, 5.51; N, 6.69. Found: C, 59.81; H, 5.58; N, 6.74. ½a D27:6
ꢁ
+3.6 (c 0.5, CH2Cl2).
(e) ((3S,30R,40R,4a0R,4b0S,9a0S)-40-Acetoxy-1-methyl-10,2-dioxo-30,40,4a0,4b0,
50,60,70,9a0-octahydro-10H-spiro[indoline-3,90-pyrano[4,3-a]pyrrolizine]-30-
or acyclic secondary amino acid (1.4 equiv) in dry toluene, was added
a,b-
unsaturated sugar lactone (1a–b) under the nitrogen atmosphere. The solution
was refluxed for 12 h in Dean–Stark apparatus to give the cycloadducts. After
completion of the reaction as indicated by TLC, the solvent was evaporated
under reduced pressure. The crude product was extracted with
dichloromethane. The organic layer was dried with anhydrous sodium
sulphate and concentrated in vacuo. The crude product was purified by
column chromatography using hexane/EtOAc (7:3) as eluent.
yl)methyl acetate (16): Isolated yield: 87% (0.338 g) Synthesized from a,b-
unsaturated sugar lactone 1b (0.2 g, 0.087 mmol), N-methyl isatin (0.141 g,
0.087 mmol), and proline (0.151 g, 0.132 mmol), white solid. Mp = 158–159 °C.
1H NMR (CDCl3, 300 MHz): d 1.84–1.85 (m, 1H), 1.97–2.00 (m, 2H), 2.11 (s, 3H),
2.12 (s, 3H), 2.21–2.23 (m, 1H), 2.56–2.64 (m, 1H), 2.71–2.81(m, 2H), 3.15 (s,
3H), 3.78 (d, J = 11.4 Hz, 1H), 4.21–4.24 (m, 1H), 4.27–4.31 (m, 2H), 5.21–5.13
(m, 1H), 5.37–5.40 (m, 1H), 6.85 (d, J = 7.8 Hz, 1H), 7.09 (t, J = 7.5 Hz, 1H), 7.33–
7.36 (m, 2H). 13 C NMR (CDCl3, 75 MHz): d 20.8, 20.9, 24.2, 26.3, 27.8, 46.4, 48.0,
49.6, 62.2, 66.5, 66.7, 73.9, 75.3, 108.8, 122.7, 124.9, 127.1, 130.1, 144.6, 169.3,
(a) ( ( 3 S , 3 a 0S,60R,70S,7a0R)-70-Acetoxy-20-methyl-2,40-dioxo-20,3a0,40,60,70,
7a0-hexahydro-10H-spiro[indoline-3,30-pyrano[4,3-c]pyrrole]-60-yl)methyl
acetate (4): Isolated yield: 84% (0.296 g) Synthesized from
a,b-unsaturated
170.1, 170.5, 176.7. IR (KBr)
C
v
max: 1745, 1698 cmꢀ1. m/z 442.19. Anal. Calcd for
sugar lactone 1a (0.2 g, 0.087 mmol), isatin (0.129, 0.087 mmol), and sarcosine
(0.117 g, 0.132 mmol),white solid. Mp = 115–116 °C. 1H NMR (CDCl3,
300 MHz): d 2.06 (s, 3H), 2.12 (s, 3H), 2.15 (s, 3H), 3.01–3.06 (m, 1H), 3.40–
3.49 (m, 1H), 3.55–3.61 (m, 1H), 3.70 (d, J = 11.1 Hz, 1H), 4.21–4.25 (m, 1H),
23H26N2O7: C, 62.43; H, 5.92; N, 6.33. Found: C, 62.33; H, 5.82; N, 6.41. ½a D26:9
ꢁ
+1.78 (c 0.3, CH2Cl2).
(f) ((3S,30R,40R,4a0R,4b0S,10a0S)-40-Acetoxy-10,2-dioxo-10,30,40,4a0,4b0,50,60,70,
80,10a0-decahydrospiro[indoline-3,100-pyrano[4,3-a]indolizine]-30-yl)methyl
4.40–4.46 (m, 1H), 5.21–5.24 (m, 1H), 5.31–5.34 (m, 1H), 6.79 (d, J = 7.5 Hz,
acetate (18): Isolated yield: 84% (0.326 g) Synthesized from a,b-unsaturated
13
1H), 7.07 (t, J = 7.5 Hz, 1H), 7.18–7.28 (m, 2H), 8.58 (s, 1H).
C NMR (CDCl3,
sugar lactone 1b (0.2 g, 0.087 mmol), isatin (0.129 g, 0.087 mmol), and
piperidine-2-carboxylic acid (0.169 g, 0.132 mmol), white solid. mp = 157–
158 °C.1H NMR (CDCl3, 300 MHz): d = 1.19–1.25 (m, 2H), 1.25–1.28 (m, 1H),
1.45–1.46 (m, 1H), 1.68 (s, 3H), 2.02 (s, 3H), 2.04–2.08 (m, 1H), 2.21–2.18 (m,
2H), 2.32–2.35 (m, 1H), 2.84–2.90 (m, 1H), 2.95–3.02 (m, 1H), 3.52–3.58 (m, 1H),
4.12–4.26 (m, 2H), 4.91–4.96 (m, 1H), 5.11–5.14 (m, 1H), 6.77 (d, J = 7.5 Hz, 1H),
7.03 (t, J = 7.5 Hz, 1H), 7.15–7.21 (m, 2H), 8.23 (s, 1H). 13 C NMR (CDCl3, 75 MHz):
d 19.2, 19.7, 22.5, 24.1, 31.2, 44.3, 44.5, 47.4, 61.1, 61.5, 64.9, 72.8, 74.0, 108.8,
75 MHz): d 20.4, 26.6, 34.2, 35.2, 51.6, 53.6, 61.4, 65.2, 73.4, 74.8, 110.1, 123.1,
123.7, 128.5, 129.6, 141.4, 169.4, 169.6, 170.4, 177.7. IR (KBr) vmax: 1710, 1743,
3290 cmꢀ1. HRMS (ESI) m/z [M+H]+ calcd for C20H23N2O7 403.1505, found
403.1509. Anal. Calcd for C20H22N2O7: C, 59.70; H, 5.51; N, 6.69. Found: C,
59.85; H, 5.63; N, 6.62. ½a D27:3
ꢁ
+3.5 (c 2.3, CH2Cl2).
(b) ((3S,30R,40S,4a0R,4b0S,9a0S)-40-Acetoxy-1-methyl-10,2-dioxo-30,40,4a0,4b0,
50,60,70,9a0-octahydro-10H-spiro[indoline-3,90-pyrano[4,3-a]pyrrolizine]-30-
yl)methyl acetate (9): Isolated yield: 88% (0.34 g) Synthesized from
a
,b-
122.3, 123.0, 127.9, 128.5, 140.2, 168.2, 168.6, 169.6, 176.4. IR (KBr) vmax: 1712,
unsaturated sugar lactone 1a (0.2 g, 0.087 mmol), N-methyl isatin (0.141 g,
0.087 mmol), and proline (0.151 g, 0.132 mmol), white solid. Mp = 164–165 °C.
1H NMR (CDCl3, 300 MHz): d 1.54–1.57 (m, 1H), 1.84–1.97 (m, 2H), 1.93–1.96
(m, 1H), 2.08 (s, 3H), 2.12 (s, 3H), 2.58–2.62 (m, 1H), 2.71–2.80 (m, 1H), 2.95–
3.01 (m, 1H), 3.15 (s, 3H), 3.87 (d, J = 11.7 Hz, 1H), 4.24–4.29 (m, 1H), 4.40–4.51
(m, 2H), 5.40–5.41 (m, 2H), 6.84 (d, J = 7.5 Hz, 1H), 7.09 (t, J = 7.5 Hz, 1H), 7.33–
7.38 (m, 2H). 13 C NMR (CDCl3, 75 MHz): d 20.7, 25.2, 26.2, 28.9, 42.0, 48.5, 52.0,
61.5, 65.1, 65.5, 73.4, 74.1, 108.8, 122.8, 124.7, 127.3, 130.0, 144.4, 169.3, 169.8,
1746, 3297 cmꢀ1. HRMS (ESI) m/z [M+H]+ calcd or C23H27N2O7 443.1818, found
443.1820. Anal. Calcd for C23H26N2O7: C, 62.43; H, 5.92; N, 6.33. Found: C, 62.51;
H, 5.86; N, 6.40. ½a D27:1
ꢁ
+ 1.10 (c 0.35, CH2Cl2).
17. The detailed X-ray crystallographic data (CCDC numbers for 9 and 16 are
827985 and 822189 respectively) are available from the Cambridge
Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK.
18. Vidhya Lakshmi, N.; Thirumurugan, P.; Perumal, P. T. Tetrahedron Lett. 2010, 51,
1064–1068.
170.6, 176.7. IR (KBr)
v
max: 1698, 1745 cmꢀ1. HRMS (ESI) m/z [M+H]+ calcd for
19. Pas niczek, K.; Socha, D.; Jurczak, M.; Frelek, J.; Suszczyn ska, A.; Lipkowska, Z.
U.; Chmielewski, M. J. Carbohydr. Chem. 2003, 22, 613–629.
C23H27N2O7 443.1818, found 443.1824. Anal. Calcd for C23H26N2O7: C, 62.43; H,
5.92; N, 6.33. Found: C, 62.54; H, 5.99; N, 6.41. ½a D26:7
ꢁ
+4 (c 0.55, CH2Cl2).